The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
The Clinical Observation of High-dose of Shenfu Injection in Treating the Refactory Heart Failure
Author(s): 
Pages: 1144-1145,1168
Year: Issue:  7
Journal: Journal of Emergency in Traditional Chinese Medicine

Keyword:  Shenfu InjectionRHFClinical observation;
Abstract: 目的 观察大剂量参附注射液治疗顽固性心力衰竭(RHF)的临床疗效.方法 将本院ICU的RHF患者60例随机分为对照组和治疗组各30例,两组均给予常规抗心力衰竭治疗,治疗组加用参附注射液静滴,疗程14 d.结果 治疗组的综合疗效与证候疗效总有效率分别为76.67%、83.33%,均优于对照组的60.00%、63.33% (P< 0.05或P<0.01);两组治疗后心脏监测指标均有改善(P<0.05),而治疗组改善程度优于对照组(P< 0.05或P<0.01).结论 大剂量参附注射液能够提高RHF的临床疗效.
Related Articles
loading...